Hedgehog Pathway Inhibitors Market To Reach USD 961.7 Million By 2026 | Reports And Data New York, Oct. 28, 2019 (GLOBE NEWSWIRE) -- High prevalence of target diseases, product launches, increasing strategic developments such as partnerships and agreements, increasing demand of painless...

Biovitrum's Project Portfolio Advances -- Pharmaceutical Project for the Treatment of Glaucoma Enters Phase I STOCKHOLM, Sweden, Sept. 13, 2005 (PRIMEZONE) -- The glaucoma candidate drug (BVT.28949) has been internally developed within Biovitrum and the first clinical study for safety testing was entered in...